Evidence map›Paper›PMID 31151471›Full record

Observational studyCritical care (London, England)2019

Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death.

Ruoting Xu, Chuhong Tan, Jiajia Zhu, Xiuli Zeng, Xuxuan Gao, Qiheng Wu, Qiong Chen, Huidi Wang, Hongwei Zhou, Yan He and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Critical care (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 5 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 5 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Gut metabolites and functional recovery after ischemic stroke: a genetic perspective.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ruoting XuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chuhong TanDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jiajia ZhuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xiuli ZengDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xuxuan GaoDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Qiheng WuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Qiong ChenDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Huidi WangDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hongwei ZhouState Key Laboratory of Organ Failure Research, Microbiome Medicine Center, Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
Yan HeState Key Laboratory of Organ Failure Research, Microbiome Medicine Center, Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China. bioyanhe@gmail.com.
Suyue PanDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China. pansuyue82@126.com.
Jia YinDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China. jiajiayin@139.com.ORCID http://orcid.org/0000-0001-8944-6604
Nanfang Hospital · CNZhujiang Hospital · CN

Funding

Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education LC2016PY025Guangdong Natural Science Foundation 2017A030313821National Natural Science Foundation of China NSFC81671171National Natural Science Foundation of China NSFC81870936
6 · The paper itself

Abstract

backgroundDespite the essential functions of the intestinal microbiota in human physiology, little has been reported about the microbiome in neurocritically ill patients. This investigation aimed to evaluate the characteristics of the gut microbiome in neurocritically ill patients and its changes after admission. Furthermore, we investigated whether the characteristics of the gut microbiome at admission were a risk factor for death within 180 days.

methodsThis prospective observational cohort study included neurocritically ill patients admitted to the neurological intensive care unit of a large university-affiliated academic hospital in Guangzhou. Faecal samples were collected within 72 h after admission (before antibiotic treatment) and serially each week. Healthy volunteers were recruited from a community in Guangzhou. The gut microbiome was monitored via 16S rRNA gene sequence analysis, and the associations with the clinical outcome were evaluated by a Cox proportional hazards model.

resultsIn total, 98 patients and 84 age- and sex-matched healthy subjects were included in the analysis. Compared with healthy subjects, the neurocritically ill patients exhibited significantly different compositions of intestinal microbiota. During hospitalization, the α-diversity and abundance of Ruminococcaceae and Lachnospiraceae decreased significantly over time in patients followed longitudinally. The abundance of Enterobacteriaceae was positively associated with the modified Rankin Scale at discharge. In the multivariate Cox regression analysis, Christensenellaceae and Erysipelotrichaceae were associated with an increased risk of death. The increases in intestinal Enterobacteriales and Enterobacteriaceae during the first week in the neurological intensive care unit were associated with increases of 92% in the risk of 180-day mortality after adjustments.

conclusionsThis analysis of the gut microbiome in 98 neurocritically ill patients indicates that the gut microbiota composition in these patients differs significantly from that in a healthy population and that the magnitude of this dysbiosis increases during hospitalization in a neurological intensive care unit. The gut microbiota characteristics seem to have an impact on patients' 180-day mortality. Gut microbiota analysis could hopefully predict outcome in the future.

Indexed as

AdultAgedChinaCohort StudiesCritical IllnessDysbiosisFecesFemaleGastrointestinal MicrobiomeHumansMaleMiddle AgedNervous System DiseasesProspective StudiesStatistics, NonparametricBiomarkerCohort studyCritical illnessDysbiosisGut microbiomePrognosisStroke

Identifiers

PMID31151471
PMCPMC6544929
OpenAlexW2947916426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.